Brief: Newbury Pharmaceuticals Secures Generic Approval For Liraglutide Pre-Filled Pen
June 20 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* SECURES GENERIC APPROVAL FOR LIRAGLUTIDE PRE-FILLED PEN
* APPROVALS IN SWEDEN AND NORWAY ARE EXPECTED TO FOLLOW UPON
FINALIZED NATIONAL REVIEWS
* ANNOUNCE SUCCESSFUL MARKETING AUTHORIZATION (MA) OF
LIRAGLUTIDE
PRE-FILLED PEN IN DENMARK
Source text for Eikon: ID:nMFN4Gl3Fz
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln